Regenxbio
RGNX
RGNX
203 hedge funds and large institutions have $2.16B invested in Regenxbio in 2018 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 92 increasing their positions, 49 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+26
Holders Change %
+14.69%
% of All Funds
4.65%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.09%
New
48
Increased
92
Reduced
49
Closed
21
Calls
$10.3M
Puts
$12.4M
Net Calls
-$2.12M
Net Calls Change
-$6.82M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$212M |
| 2 |
2
BlackRock
New York
|
$357M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$37.1M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$128M |
| 5 |
5
Renaissance Technologies
New York
|
$21.6M |
Top Sellers
| 1 |
RI
1
RTW Investments
New York
|
$110M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$82.7M |
| 3 |
PA
3
Perceptive Advisors
New York
|
$35.5M |
| 4 |
4
Adage Capital Partners
Boston,
Massachusetts
|
$0 |
| 5 |
5
Citigroup
New York
|
$6.66M |
